Synovate Healthcare appoints new CFO


19 November 2004

LONDON — SYNOVATE Healthcare has announced the appointment of Simon Woodlock as Chief Financial Officer. He will take up the position in January 2005.

Woodlock was at NOP World for eight years, serving as CFO of NOP Research Group and, more recently, European Chief Financial Officer. He was a member of the NOP Research Group Board of Directors.

At NOP World he focused on the strategic financial management of divisions within the UK, Germany, Italy and the Philippines, and spearheaded a change management process within the US accounting functions. In addition to implementing management information systems at NOP Research, he was also a leader in corporate development strategy and execution, the most recent project being the Eurisko acquisition.

Prior to joining NOP, Woodlock held financial positions at Direct Line and Landis & Gyr Communications, within the insurance and telecommunications sectors. A Chartered Management Accountant, he holds a BA (Hons) from Kingston University and has lived in the Middle East, Bermuda, the Seychelles and Hong Kong. He will continue to be based in the UK.


Contact(s) for this press release


Alicia Kan
Global Head of Communications

Telephone: +1 312 526 4570
Send an email




About Synovate Healthcare

Synovate Healthcare is the global specialist healthcare market research arm of Synovate, dedicated to delivering marketing insights to the pharmaceutical and healthcare industries. Synovate Healthcare employs 500 healthcare market research professionals across Europe, US, Canada, Asia Pacific and Japan and offers global fieldwork capabilities.

More information on Synovate Healthcare can be found at www.synovate.com/healthcare.



About Synovate

Synovate, the market research arm of Aegis Group plc, generates consumer insights that drive competitive marketing solutions. The network provides clients with cohesive global support and a comprehensive suite of research solutions. Synovate employs over 6,000 staff across 62 countries.

For more information on Synovate visit www.synovate.com.